BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30402704)

  • 1. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
    Xie T; Zhao Q; Fu C; Bai Q; Zhou X; Li L; Grimm R; Liu L; Gu Y; Peng W
    Eur Radiol; 2019 May; 29(5):2535-2544. PubMed ID: 30402704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-tumor histogram analysis of multiparametric breast magnetic resonance imaging to differentiate pure mucinous breast carcinomas from fibroadenomas with high-signal intensity on T2WI.
    Li X; Chai W; Sun K; Zhu H; Yan F
    Magn Reson Imaging; 2024 Feb; 106():8-17. PubMed ID: 38035946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
    Agner SC; Rosen MA; Englander S; Tomaszewski JE; Feldman MD; Zhang P; Mies C; Schnall MD; Madabhushi A
    Radiology; 2014 Jul; 272(1):91-9. PubMed ID: 24620909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
    Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
    Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Prognostic Factors and Molecular Subtypes of Breast Cancer With a Continuous-Time Random-Walk MR Diffusion Model: Using Whole Tumor Histogram Analysis.
    Qin Y; Tang C; Hu Q; Yi J; Yin T; Ai T
    J Magn Reson Imaging; 2023 Jul; 58(1):93-105. PubMed ID: 36251468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histogram analysis of quantitative parameters from synthetic MRI: Correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer.
    Li Q; Xiao Q; Yang M; Chai Q; Huang Y; Wu PY; Niu Q; Gu Y
    Eur J Radiol; 2021 Jun; 139():109697. PubMed ID: 33857828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer molecular subtype classifier that incorporates MRI features.
    Sutton EJ; Dashevsky BZ; Oh JH; Veeraraghavan H; Apte AP; Thakur SB; Morris EA; Deasy JO
    J Magn Reson Imaging; 2016 Jul; 44(1):122-9. PubMed ID: 26756416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
    Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
    Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogram Analysis and Visual Heterogeneity of Diffusion-Weighted Imaging with Apparent Diffusion Coefficient Mapping in the Prediction of Molecular Subtypes of Invasive Breast Cancers.
    Horvat JV; Iyer A; Morris EA; Apte A; Bernard-Davila B; Martinez DF; Leithner D; Sutton OM; Ochoa-Albiztegui RE; Giri D; Pinker K; Thakur SB
    Contrast Media Mol Imaging; 2019; 2019():2972189. PubMed ID: 31819738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
    Du S; Gao S; Zhang L; Yang X; Qi X; Li S
    Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
    Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
    Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Luo HB; Du MY; Liu YY; Wang M; Qing HM; Wen ZP; Xu GH; Zhou P; Ren J
    Acad Radiol; 2020 Mar; 27(3):e35-e44. PubMed ID: 31151899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer.
    You C; Li J; Zhi W; Chen Y; Yang W; Gu Y; Peng W
    J Transl Med; 2019 Jul; 17(1):182. PubMed ID: 31262334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomic analysis on magnetic resonance diffusion weighted image in distinguishing triple-negative breast cancer from other subtypes: a feasibility study.
    Wang Q; Mao N; Liu M; Shi Y; Ma H; Dong J; Zhang X; Duan S; Wang B; Xie H
    Clin Imaging; 2021 Apr; 72():136-141. PubMed ID: 33242692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved value of whole-lesion histogram analysis on DCE parametric maps for diagnosing small breast cancer (≤ 1 cm).
    Xie T; Zhao Q; Fu C; Grimm R; Gu Y; Peng W
    Eur Radiol; 2022 Mar; 32(3):1634-1643. PubMed ID: 34505195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of histogram analysis of apparent diffusion coefficient maps for differentiating triple-negative breast cancer from other subtypes of breast cancer on standard MRI.
    Liu HL; Zong M; Wei H; Wang C; Lou JJ; Wang SQ; Zou QG; Jiang YN
    Cancer Manag Res; 2019; 11():8239-8247. PubMed ID: 31564982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
    Chamming's F; Ueno Y; Ferré R; Kao E; Jannot AS; Chong J; Omeroglu A; Mesurolle B; Reinhold C; Gallix B
    Radiology; 2018 Feb; 286(2):412-420. PubMed ID: 28980886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.